Skip to main content

Animations

MJFF Publications

3091 - 3100 of 6420 Results
Title
Year
  • Year
  • 2022
  • 2018
  • 2021
  • 2022
  • 2020
  • 2024
  • 2023
  • 2024
  • 2024
  • 2025
  • Summary Details
    OPEN
    Title: Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients
    Journal Name: Clinical and Translational Discovery
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/ctd2.96
    Citation Count: 6
  • Summary Details
    OPEN
    Title: A comprehensive analysis of SNCA‐related genetic risk in sporadic parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25274
    Citation Count: 60
  • Summary Details
    OPEN
    Title: SORL1 mutation in a Greek family with Parkinson's disease and dementia
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51433
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Association of Cerebrospinal Fluid Neurofilament Heavy Protein Levels With Clinical Progression in Patients With Parkinson Disease
    Journal Name: JAMA Network Open
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.23821
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.3311
    Citation Count: 199
  • Summary Details
    OPEN
    Title: Single-cell spatial transcriptomic and translatomic profiling of dopaminergic neurons in health, aging, and disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2024.113784
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias
    Journal Name: Cell Genomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.xgen.2023.100316
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Replication and reliability of Parkinson's disease clinical subtypes
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107016
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Tagless LysoIP for immunoaffinity enrichment of native lysosomes from clinical samples
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1172/jci183592
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Segregated basal ganglia output pathways correspond to genetically divergent neuronal subclasses
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.115454
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.